Evidence update log
A live log of the most recently reviewed and enriched evidence pages on Peptide Authority — peptide profiles and condition guides, sorted by review date.
Last reviewed:
Peptide Authority continuously enriches its evidence content. This page surfaces (a) the peptide profiles that have a full Evidence Standards Panel (12 structured fields including human-evidence grade, claim-vs-evidence, safety uncertainty, research gaps, safer alternatives) seeded, and (b) the symptom guides that have the full standard-care / when-to-see-GP / approved-treatments / evidence-table top panel populated. Sorted by review date, most-recent first.
Peptide profile coverage
71 / 71 fully seeded
Profiles without seeded data render the honest fallback panel and are enriched in priority order.
Symptom guide coverage
45 / 60 fully seeded
Guides without the standard-care template render the legacy template; the new panel is added in traffic-order.
Most-recently reviewed peptide profiles
Top 30, by “last reviewed” date. The presence of an entry here means the profile has been substantively reviewed and graded against our evidence-grading methodology.
- Tesofensine2026-09-25
- Ipamorelin2026-09-25
- Leptin2026-09-25
- Tirzepatide2026-09-25
- Retatrutide2026-09-25
- SS-312026-09-25
- MK-6772026-09-25
- PACAP (Pituitary Adenylate Cyclase-Activating Peptide)2026-09-25
- Survodutide2026-03-13
- Cagrilintide2026-03-13
- CJC-1295 DAC2026-03-13
- ARA-2902026-03-13
- Thymalin2026-03-13
- Humanin2026-03-08
- GnRH2026-03-08
- Defensins2026-03-08
- Substance P2026-03-08
- Collagen Peptides2026-03-08
- Pentosan Polysulfate2026-03-08
- NAD+2026-03-08
- KPV2026-02-22
- Cerebrolysin2026-02-22
- Palmitoyl Tripeptide-12026-02-22
- Syn-Ake2026-02-04
- Matrixyl2026-02-03
- Argireline2026-02-03
- SNAP-82026-02-03
- Leuphasyl2026-02-03
- Dihexa2026-02-03
- TB-5002026-02-02
Most-recently reviewed symptom guides
Top 20, by “last reviewed” date. These guides lead with standard UK care, NHS pathways, and an honest evidence table before any peptide-research discussion.
- Peptides for Weight Loss2026-09-25
- Peptides for Neuropathy & Nerve Health2026-09-25
- Peptides for Erectile Dysfunction & Sexual Performance2026-03-27
- Peptides for Infertility: Male & Female Fertility Research2026-03-27
- Peptides for Osteoarthritis & Joint Health2026-03-27
- Peptides for Menopause: Hot Flashes, Bone Loss, Skin & Mood2026-03-27
- Peptides for Migraine Prevention2026-03-27
- Peptides for Neuropathic Pain & Nerve Damage2026-03-27
- Peptides for Disc Degeneration & Back Pain2026-03-27
- Peptides for Frozen Shoulder Recovery2026-03-27
- Peptides for Bone Density & Osteoporosis Prevention2026-03-27
- Peptides for Cardiovascular Health & Heart Protection2026-03-27
- Peptides for Thyroid Function & Support2026-03-27
- Peptides for Diabetes & Blood Sugar Control2026-03-24
- Peptides for Bodybuilding & Muscle Gain2026-03-24
- Peptides for Knee Pain & Joint Support2026-03-24
- Peptides for Back Pain & Spinal Health2026-03-24
- Peptides for IBS & Digestive Disorders2026-03-24
- Peptides for Depression & Mood Support2026-03-24
- Peptides for PCOS (Polycystic Ovary Syndrome)2026-03-24
What “reviewed” means here
A peptide profile is “reviewed” in this log if it has:
- A graded UK regulatory status pill (licensed / POM / unlicensed / research-only).
- A graded evidence grade against our A–E system.
- Human and preclinical evidence grades populated.
- An explicit list of approved and unapproved-but-marketed claims.
- A claim-vs-evidence matrix for the most-marketed assertions.
- Safety uncertainty and drug-interaction uncertainty scores.
- A “what this page cannot tell you” honest-limits section.
- Research gaps and safer-alternatives sections.
A guide is “reviewed” if it has the standard-care, GP-trigger, UK-approved-treatments, and honest evidence-table fields populated.